{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:22:30Z","timestamp":1788636150818,"version":"build-2803163510"},"reference-count":23,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Appl Biosaf."],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The Animal Biosafety Level 3 Enhanced (ABSL-3+) laboratory at St. Jude Children's Research Hospital has a long history of influenza pandemic preparedness. The emergence of SARS-CoV-2 and subsequent expansion into a pandemic has put new and unanticipated demands on laboratory operations since April 2020. Administrative changes, investigative methods requiring increased demand for inactivation and validation of sample removal, and the adoption of a new animal model into the space required all arms of our Biorisk Management System (BMS) to respond with speed and innovation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In this report, we describe the outcomes of three major operational changes that were implemented to adapt the ABSL-3+ select agent space into a multipathogen laboratory. First were administrative controls that were revised and developed with new Institutional Biosafety Committee protocols, laboratory space segregation, training of staff, and occupational health changes for potential exposure to SARS-CoV-2 inside the laboratory. Second were extensive inactivation and validation experiments performed for both highly pathogenic avian influenza and SARS-CoV-2 to meet the demands for sample removal to a lower biosafety level. Third was the establishment of a new caging system to house Syrian Golden hamsters for SARS-CoV-2 risk assessment modeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary:<\/jats:title>\n                    <jats:p>The demands placed on biocontainment laboratories for response to SARS-CoV-2 has highlighted the importance of a robust BMS. In a relatively short time, the ABSL-3+ was able to adapt from a single select agent space to a multipathogen laboratory and expand our pandemic response capacity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/apb.2021.0030","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T13:56:17Z","timestamp":1643032577000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["It's the Wrong Virus: Rapid Adaptation of Operations Inside a Highly Pathogenic Avian Influenza Select Agent Laboratory in Response to the 2019 SARS-CoV-2 Pandemic"],"prefix":"10.1177","volume":"27","author":[{"given":"Lisa","family":"Kercher","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and St. Jude Children's Research Hospital, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Seiler","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and St. Jude Children's Research Hospital, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trushar","family":"Jeevan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and St. Jude Children's Research Hospital, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Franks","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and St. Jude Children's Research Hospital, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Trifkovic","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and St. Jude Children's Research Hospital, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindumadhav","family":"Marathe","sequence":"additional","affiliation":[{"name":"Department of Environmental Health and Safety, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Henry","sequence":"additional","affiliation":[{"name":"Department of Environmental Health and Safety, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Gaut","sequence":"additional","affiliation":[{"name":"Department of Environmental Health and Safety, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Webby","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and St. Jude Children's Research Hospital, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"e_1_3_6_2_2","unstructured":"Jilani TN Jamil RT Siddiqui AH . H1N1 Influenza. StatPearls. 2021. https:\/\/pubmed.ncbi.nlm.nih.gov\/30020613\/. Accessed October4 2021."},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.720315"},{"key":"e_1_3_6_4_2","author":"De Benedictis P","year":"2007","unstructured":"De Benedictis P, , Beato MS, , Capua I. Inactivation of avian influenza viruses by chemical agents and physical conditions: a review. Zoonoses Public Health. 2007;54(2):51\u201368.","journal-title":"Zoonoses Public Health"},{"key":"e_1_3_6_5_2","author":"Haddock E","year":"2016","unstructured":"Haddock E, , Feldmann F, , Feldmann H, . Effective chemical inactivation of Ebola virus. Emerg Infect Dis. 2016;22(7):1292\u20131294.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_6_6_2","author":"Haddock E","year":"2021","unstructured":"Haddock E, , Feldmann F, , Shupert WL, , Feldmann H, . Inactivation of SARS-CoV-2. Am J Trop Med Hyg. 2021;104(6):2195\u20132198.","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12060622"},{"key":"e_1_3_6_8_2","author":"Imai M","year":"2020","unstructured":"Imai M, , Iwatsuki-Horimoto K, , Hatta M, et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A. 2020;117(28):16587\u201316595.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_6_9_2","author":"Sia SF","year":"2020","unstructured":"Sia SF, , Yan LM, , Chin AWH, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834\u2013838.","journal-title":"Nature"},{"key":"e_1_3_6_10_2","volume-title":"The Laboratory Rabbit, Guinea Pig, Hamster, and other Rodents","author":"Suckow MA","year":"2012","unstructured":"Suckow MA, , Stevens KA, , Wilson RP, eds. The Laboratory Rabbit, Guinea Pig, Hamster, and other Rodents. London: Academic Press; 2012."},{"key":"e_1_3_6_11_2","author":"Lombardi ME","year":"2008","unstructured":"Lombardi ME, , Ladman BS, , Alphin RL, , Benson ER. Inactivation of avian influenza virus using common detergents and chemicals. Avian Dis. 2008;52(1):118\u2013123.","journal-title":"Avian Dis"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12060624"},{"key":"e_1_3_6_13_2","author":"Patterson EI","year":"2020","unstructured":"Patterson EI, , Prince T, , Anderson ER, et al. Methods of inactivation of SARS-CoV-2 for downstream biological assays. J Infect Dis. 2020;222(9):1462\u20131467.","journal-title":"J Infect Dis"},{"key":"e_1_3_6_14_2","author":"Kap M","year":"2013","unstructured":"Kap M, , Arron GI, , Loibner M, et al. Inactivation of influenza A virus, adenovirus, and cytomegalovirus with PAXgene tissue fixative and formalin. Biopreserv Biobank. 2013;11(4):229\u2013234.","journal-title":"Biopreserv Biobank"},{"key":"e_1_3_6_15_2","author":"Lifson JD","year":"1986","unstructured":"Lifson JD, , Sasaki DT, , Engleman EG, . Utility of formaldehyde fixation for flow cytometry and inactivation of the AIDS associated retrovirus. J Immunol Methods. 1986;86(1):143\u2013149.","journal-title":"J Immunol Methods"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2017.09.025"},{"key":"e_1_3_6_17_2","author":"Nicholls JM","year":"2012","unstructured":"Nicholls JM, , Wong LP, , Chan RW, et al. Detection of highly pathogenic influenza and pandemic influenza virus in formalin fixed tissues by immunohistochemical methods. J Virol Methods. 2012;179(2):409\u2013413.","journal-title":"J Virol Methods"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-289"},{"key":"e_1_3_6_19_2","author":"Fox CH","year":"1985","unstructured":"Fox CH, , Johnson FB, , Whiting J, , Roller PP. Formaldehyde fixation. J Histochem Cytochem. 1985;33(8):845\u2013853.","journal-title":"J Histochem Cytochem"},{"key":"e_1_3_6_20_2","author":"van Kampen JJA","year":"2017","unstructured":"van Kampen JJA, , Tintu A, , Russcher H, et al. Ebola virus inactivation by detergents is annulled in serum. J Infect Dis. 2017;216(7):859\u2013866.","journal-title":"J Infect Dis"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12070735"},{"key":"e_1_3_6_22_2","author":"Swayne DE","year":"2004","unstructured":"Swayne DE, , Beck JR, . Heat inactivation of avian influenza and Newcastle disease viruses in egg products. Avian Pathol. 2004;33(5):512\u2013518.","journal-title":"Avian Pathol"},{"key":"e_1_3_6_23_2","unstructured":"Report on the Potential Exposure to Anthrax (Centers for Disease Control and Prevention). 2014. https:\/\/www.cdc.gov\/labs\/pdf\/Final_Anthrax_Report.pdf. Accessed September16 2021."},{"key":"e_1_3_6_24_2","author":"Chan JF","year":"2020","unstructured":"Chan JF, , Yuan S, , Zhang AJ, et al. Surgical mask partition reduces the risk of noncontact transmission in a golden Syrian hamster model for coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2020;71(16):2139\u20132149.","journal-title":"Clin Infect Dis"}],"container-title":["Applied Biosafety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/apb.2021.0030","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/apb.2021.0030","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/apb.2021.0030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:38:18Z","timestamp":1777376298000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/apb.2021.0030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6,1]]}},"alternative-id":["10.1089\/apb.2021.0030"],"URL":"https:\/\/doi.org\/10.1089\/apb.2021.0030","relation":{},"ISSN":["1535-6760","2470-1246"],"issn-type":[{"value":"1535-6760","type":"print"},{"value":"2470-1246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]}}}